That said, Kate has shared regular updates on her experience with cancer and treatment. She first revealed her cancer diagnosis in March 2024, sharing that she'd be undergoing chemotherapy.
LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...